India Multiple Sclerosis Therapies Market (2025-2031) | Segmentation, Growth, Size & Revenue, Forecast, Analysis, Trends, Industry, Competitive Landscape, Share, Companies, Value, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Multiple Sclerosis Therapies Market Revenues & Volume, 2021 & 2031F

3.3 India Multiple Sclerosis Therapies Market - Industry Life Cycle

3.4 India Multiple Sclerosis Therapies Market - Porter's Five Forces

3.5 India Multiple Sclerosis Therapies Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 India Multiple Sclerosis Therapies Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 India Multiple Sclerosis Therapies Market Revenues & Volume Share, By End user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of multiple sclerosis in India

4.2.2 Growing awareness about the disease and available treatment options

4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in India

4.3 Market Restraints

4.3.1 High cost associated with multiple sclerosis therapies

4.3.2 Limited access to advanced treatments in rural areas of India

4.3.3 Stringent regulations and approval processes for new therapies

6.1 India Multiple Sclerosis Therapies Market, By Type

6.1.1 Overview and Analysis

6.1.2 India Multiple Sclerosis Therapies Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 India Multiple Sclerosis Therapies Market Revenues & Volume, By Immunosuppressants, 2021- 2031F

6.1.4 India Multiple Sclerosis Therapies Market Revenues & Volume, By Immunomodulators, 2021- 2031F

6.2 India Multiple Sclerosis Therapies Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 India Multiple Sclerosis Therapies Market Revenues & Volume, By Oral, 2021- 2031F

6.2.3 India Multiple Sclerosis Therapies Market Revenues & Volume, By Injectable, 2021- 2031F

6.2.4 India Multiple Sclerosis Therapies Market Revenues & Volume, By Intravenous, 2021- 2031F

6.3 India Multiple Sclerosis Therapies Market, By End user

6.3.1 Overview and Analysis

6.3.2 India Multiple Sclerosis Therapies Market Revenues & Volume, By Hospital, 2021- 2031F

6.3.3 India Multiple Sclerosis Therapies Market Revenues & Volume, By Clinics, 2021- 2031F

6.3.4 India Multiple Sclerosis Therapies Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F

6.3.5 India Multiple Sclerosis Therapies Market Revenues & Volume, By Others, 2021- 2031F

7.1 India Multiple Sclerosis Therapies Market Export to Major Countries

7.2 India Multiple Sclerosis Therapies Market Imports from Major Countries

8.1 Patient adherence rate to prescribed therapies

8.2 Number of clinical trials for new multiple sclerosis treatments conducted in India

8.3 Percentage of neurologists trained in multiple sclerosis management in India

9.1 India Multiple Sclerosis Therapies Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 India Multiple Sclerosis Therapies Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 India Multiple Sclerosis Therapies Market Opportunity Assessment, By End user, 2021 & 2031F

10.1 India Multiple Sclerosis Therapies Market Revenue Share, By Companies, 2024

10.2 India Multiple Sclerosis Therapies Market Competitive Benchmarking, By Operating and Technical Parameters